-
1 Comment
Pfizer Limited is currently in a long term uptrend where the price is trading 13.4% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 9.5.
Pfizer Limited's total revenue rose by 5.0% to $6B since the same quarter in the previous year.
Its net income has dropped by 14.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 54.2% to $3B since the same quarter in the previous year.
Based on the above factors, Pfizer Limited gets an overall score of 3/5.
| Exchange | NSE |
|---|---|
| CurrencyCode | INR |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| ISIN | INE182A01018 |
| Beta | 0.21 |
|---|---|
| Market Cap | 197B |
| PE Ratio | 31.99 |
| Dividend Yield | 0.8% |
| Target Price | 5971.6665 |
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare providers, government and private hospitals, and retail pharmacies. The company sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PFIZER.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
